These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24975751)

  • 1. Prevalence of diabetes and impaired fasting glucose in Poland--the NATPOL 2011 Study.
    Rutkowski M; Bandosz P; Czupryniak L; Gaciong Z; Solnica B; Jasiel-Wojculewicz H; Wyrzykowski B; Pencina MJ; Zdrojewski T
    Diabet Med; 2014 Dec; 31(12):1568-71. PubMed ID: 24975751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of diabetes and impaired fasting glucose in Poland in 2005-2014: results of the WOBASZ surveys.
    Rutkowski M; Wojciechowska A; Śmigielski W; Drygas W; Piwońska A; Pająk A; Tykarski A; Kozakiewicz K; Waśniewska MK; Zdrojewski T
    Diabet Med; 2020 Sep; 37(9):1528-1535. PubMed ID: 32445422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)].
    Łopatyński J; Mardarowicz G; Nicer T; Szcześniak G; Król H; Matej A; Szydłowski W; Paszkowski J; Dabek K; Zmurowska B; Szyprowska-Grzegorczyk E
    Pol Arch Med Wewn; 2001 Sep; 106(3):781-6. PubMed ID: 11928586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of impaired glucose tolerance and diabetes mellitus in subjects with fasting blood glucose below 6.1 mmol/L (110 mg/dL).
    Khan SH; Ijaz A; Bokhari SA; Hanif MS; Azam N
    East Mediterr Health J; 2013 Feb; 19(2):175-80. PubMed ID: 23516829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study.
    Hussain A; Vaaler S; Sayeed MA; Mahtab H; Ali SM; Khan AK
    Eur J Public Health; 2007 Jun; 17(3):291-6. PubMed ID: 17008328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diabetes mellitus and other abnormalities of glucose tolerance in young adults aged 20-40 years in North India (Kashmir Valley).
    Zargar AH; Wani AA; Laway BA; Masoodi SR; Wani AI; Bashir MI; Dar FA
    Diabetes Res Clin Pract; 2008 Nov; 82(2):276-81. PubMed ID: 18814927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors.
    Al-Habori M; Al-Mamari M; Al-Meeri A
    Diabetes Res Clin Pract; 2004 Sep; 65(3):275-81. PubMed ID: 15331208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of postpartum impaired glucose tolerance after gestational diabetes].
    Romero Gutiérrez G; Macias Rocha AL; Puente Alvarez EI
    Ginecol Obstet Mex; 2012 Oct; 80(10):631-6. PubMed ID: 23240225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.
    Hoffmann IS; Alfieri AB; Cubeddu LX
    Am J Ther; 2013; 20(4):369-75. PubMed ID: 23528370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in the Punjab Province of Pakistan.
    Shera AS; Basit A; Fawwad A; Hakeem R; Ahmedani MY; Hydrie MZ; Khwaja IA
    Prim Care Diabetes; 2010 Jul; 4(2):79-83. PubMed ID: 20149776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for the detection of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in welfare homes residents from south-eastern region of Poland.
    Grzywa M; Mazur A; Skrzypiec J
    Int J Clin Pract; 2011 Jul; 65(7):818-9. PubMed ID: 21676124
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey.
    Zdrojewski T; Rutkowski M; Bandosz P; Gaciong Z; Jędrzejczyk T; Solnica B; Pencina M; Drygas W; Wojtyniak B; Grodzicki T; Piwoński J; Wyrzykowski B
    Kardiol Pol; 2013; 71(4):381-92. PubMed ID: 23788344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.